-transparent.png){kind=logo}
Glutamic acid-553 of Pseudomonas aeruginosa exotoxin A (ETA), identified previously as an active-site residue, was deleted by oligonucleotide-directed mutagenesis of the cloned toxin gene in Escherichia coli. The purified mutant toxin was stable, fully immunoreactive, and capable of blocking toxin receptors. ADP-ribosyltransferase and cytotoxic activities were at least 10(6)-fold lower than those of wild-type ETA, and injection of mice with 50 micrograms (equivalent to 400 lethal doses of ETA) produced no ill effects. The mutant toxin elicited high levels of neutralizing anti-ETA antibodies in mice, which protected against a challenge with 100 micrograms of authentic ETA (greater than 600 lethal doses). The mutant protein has the attributes of a toxoid and may be useful as a component of vaccines for individuals at risk for infection by P. aeruginosa.
M Lukac, and
G B Pier, and
R J Collier
January 1995,
The Journal of biological chemistry,
M Lukac, and
G B Pier, and
R J Collier
January 1988,
Proteins,
M Lukac, and
G B Pier, and
R J Collier
May 1982,
The Journal of infectious diseases,
M Lukac, and
G B Pier, and
R J Collier
May 1999,
The Journal of biological chemistry,
M Lukac, and
G B Pier, and
R J Collier
February 1992,
Biochimica et biophysica acta,
M Lukac, and
G B Pier, and
R J Collier
January 1992,
Current topics in microbiology and immunology,
M Lukac, and
G B Pier, and
R J Collier
May 1983,
Proceedings of the National Academy of Sciences of the United States of America,
M Lukac, and
G B Pier, and
R J Collier
January 1992,
Targeted diagnosis and therapy,
M Lukac, and
G B Pier, and
R J Collier
June 1980,
The New England journal of medicine,
M Lukac, and
G B Pier, and
R J Collier
October 1982,
Zhurnal mikrobiologii, epidemiologii i immunobiologii,
